ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jan 19, 2012
Best-Idea eBay Reports Fantastic Fourth-Quarter Results; Outlook Tempered, as Expected
Global e-commerce giant eBay reported fantastic fourth-quarter results that showed impressive growth in its online payment processor, PayPal. We'll be looking to add to our position in eBay in the portfolio of our Best Ideas Newsletter.
Jan 18, 2012
Lack of Winter Weather Hits Dick’s Sporting Goods and Big 5; We’re Not Fans of Either
We take a look at two sporting goods retailers. Dick's Sporting Goods' risk/reward isn't that compelling at this time, while Big 5 is getting cheap again, and its dividend could pay you to wait out the storm.
Jan 16, 2012
Valuentum's January Edition of Its Best Ideas Newsletter!
The January edition of our Best Ideas Newsletter is now available.
Jan 13, 2012
JP Morgan Posts Fourth-Quarter Results; Sees Improving Loan Demand and Credit Quality
The largest US bank, by assets, posted fourth-quarter results. Though profit faced pressure due to declining investment-banking business, underlying trends with respect to JP Morgan's loan growth and credit quality were very encouraging. The bank continues to have a fortress balance sheet.
Jan 11, 2012
Lennar's Order and Backlog Growth Impressive; Housing Market on the Mend
Homebuilder Lennar reported fourth-quarter results that showed solid increases in new home orders and backlog. Though its financial services and distressed asset management arms hurt earnings, we think the firm's results reveal a unique and long-awaited firming in housing demand.
Jan 11, 2012
Lululemon Raises Guidance; Our Valuation Remains Unchanged
With room for growth both in North America and abroad, we think Lululemon remains a growth company that could yield high returns for those with high risk tolerance. However, with shares trading up from $42 to $60 in less than a month, we'd wait for a larger margin of safety before getting too excited about the name.
Jan 10, 2012
Life Technologies Unveils One-Day Genome Sequencer Product; Shares Jump 8% to Our $47 Fair Value Estimate
Life Technologies announced that it has begun accepting orders for a product named the Ion Proton Sequencer that could sequence a person's entire genome in just one day (more expensive, competing machines can take weeks or longer to do the same procedure). We had been expecting valuation upside from the firm, and its shares have now converged to our $47 fair value estimate.
Jan 10, 2012
Alcoa Posts Weak Fourth-Quarter Results, Will Focus on Preserving Cash Balance in 2012
Alcoa posted weak fourth-quarter results, though its outlook for the aerospace and automotive end markets remain strong. The aluminum giant will manage operations to maximize cash flow during 2012 amid ongoing weakness in aluminum pricing.
Jan 9, 2012
Despite Market Uncertainty, Our Best Ideas Portfolio Continues to Widen Outperformance
The portfolio in our Best Ideas Newsletter is now outpacing the S&P 500 (SPY) by over 20 percentage points through January 7, 2012. View an interim-issue snapshop of our performance.
Jan 9, 2012
Stick to the Smoothies, Not the Stock with Jamba
We don't find Jamba that compelling and encourage investors to steer clear of this penny stock. We think it is priced appropriately on the basis of option value, considering its debt-free balance sheet and still-improving same-store-sales trends.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.